Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Consolidated net income (loss)	$ 36,042	$ (105,060)
Adjustments to reconcile consolidated net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	22,709	23,033
Non-cash operating lease cost	4,379	4,940
Stock-based compensation to employees and directors	8,356	13,623
Impairment of equity securities	813	6,964
Income (Loss) from Equity Method Investments	(11,909)	(4,922)
Gain on disposal of business	10,705	0
Impairment of Intangible Assets, Finite-lived	0	1,406
Other non-cash adjustments	2,587	1,978
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net	(15,715)	12,858
Inventories	(1,027)	6,864
Prepaids and other current assets	(42)	5,473
Other long-term assets, net	26	(1,046)
Accounts payable	44,101	(42,110)
Accrued liabilities	59,657	(8,683)
Unearned revenue	37,161	(10,066)
Operating lease liabilities	(4,954)	(4,086)
Other long-term liabilities	3,413	(205)
Net cash provided by (used in) operating activities	198,710	(89,195)
Cash flows from investing activities:
Purchase of equity securities	(1,553)	(5,106)
Proceeds from sale of equity securities and marketable securities	6,306	7,082
Acquisitions of businesses, net of cash acquired	0	4,886
Expenditures for property and equipment	(15,067)	(17,902)
Deconsolidation of cash of Medici Land Governance, Inc.	(4,056)	0
Other investing activities, net	(1,061)	(3,219)
Net cash used in investing activities	(15,431)	(14,259)
Cash flows from financing activities:
Payments on long-term debt	(1,566)	(3,141)
Proceeds from long-term debt	47,500	0
Proceeds from sale of common stock, net of offering costs	195,540	52,112
Payments of taxes withheld upon vesting of restricted stock	(2,317)	(1,373)
Other financing activities, net	(5,054)	(1,161)
Net cash provided by financing activities	234,103	46,437
Net increase (decrease) in cash, cash equivalents and restricted cash	417,382	(57,017)
Cash, cash equivalents and restricted cash, beginning of period	114,898	142,814
Cash, cash equivalents and restricted cash, end of period	532,280	85,797
Non-cash investing and financing activities:
Recognition of right-of-use assets upon adoption of ASC 842	0	30,968
Deposit applied to business combination purchase price	$ 0	$ 7,347